ProQuest Associates IV LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 65 filers reported holding UROGEN PHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
ProQuest Associates IV LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2018$37,278,000
-5.1%
789,2970.0%70.39%
+16.5%
Q2 2018$39,275,000
-27.9%
789,297
-28.0%
60.44%
-3.5%
Q1 2018$54,461,000
+33.5%
1,096,0240.0%62.61%
+15.6%
Q4 2017$40,783,000
-10.8%
1,096,024
-24.4%
54.17%
+18.3%
Q3 2017$45,696,000
+74.3%
1,449,745
-0.1%
45.77%
+36.6%
Q2 2017$26,211,0001,451,32933.51%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,252,285$24,156,0007.72%
Horton Capital Management, LLC 375,428$7,242,0006.96%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$56,996,0001.27%
Phoenix Holdings Ltd. 901,979$16,405,0000.69%
SHIKIAR ASSET MANAGEMENT INC 44,550$859,0000.33%
Coastal Bridge Advisors, LLC 37,000$714,0000.22%
Migdal Insurance & Financial Holdings Ltd. 738,302$14,242,0000.20%
Clal Insurance Enterprises Holdings Ltd 529,388$10,212,0000.17%
Vivaldi Capital Management LP 10,000$233,0000.05%
MEITAV INVESTMENT HOUSE LTD 48,407$934,0000.05%
View complete list of UROGEN PHARMA LTD shareholders